Common Contracts

ROVI CORPORATION, TIVO CORPORATION AND as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of September 7, 2016

First Supplemental Indenture • September 8th, 2016 • Titan Technologies Corp • Patent owners & lessors • New York

• Contract Type
  First Supplemental Indenture
• Filed
  September 8th, 2016
• Company
  Titan Technologies Corp
• Industry
  Patent owners & lessors
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of September 7, 2016 (this “Supplemental Indenture”), among ROVI CORPORATION, a Delaware corporation (the “Company”), TIVO CORPORATION, a Delaware corporation (f/k/a Titan Technologies Corporation) (the “Guarantor”), and U.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee”), to the Indenture, dated as of March 4, 2015 (the “Indenture”), between the Company and the Trustee.

ROVI CORPORATION, TIVO CORPORATION AND as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of September 7, 2016

First Supplemental Indenture • September 8th, 2016 • Rovi Corp • Patent owners & lessors • New York

• Contract Type
  First Supplemental Indenture
• Filed
  September 8th, 2016
• Company
  Rovi Corp
• Industry
  Patent owners & lessors
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of September 7, 2016 (this “Supplemental Indenture”), among ROVI CORPORATION, a Delaware corporation (the “Company”), TIVO CORPORATION, a Delaware corporation (f/k/a Titan Technologies Corporation) (the “Guarantor”), and U.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee”), to the Indenture, dated as of March 4, 2015 (the “Indenture”), between the Company and the Trustee.

HORIZON PHARMA, INC., HORIZON PHARMA PUBLIC LIMITED COMPANY AND as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of September 19, 2014

First Supplemental Indenture • September 19th, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  First Supplemental Indenture
• Filed
  September 19th, 2014
• Company
  Horizon Pharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of September 19, 2014 (this “Supplemental Indenture”), among HORIZON PHARMA, INC., a Delaware corporation (the “Company”), HORIZON PHARMA PUBLIC LIMITED COMPANY, a public limited company organized under the laws of Ireland (f/k/a Vidara Thereapeutics International Public Limited Company; f/k/a Vidara Therapeutics International Limited) (“Guarantor”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”), to the Indenture, dated as of November 22, 2013 (the “Indenture”), between the Company and the Trustee.